- Home
- MLTX vs CPRX Comparison
MLTX vs CPRX Comparison
Compare MLTX & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLTX
- CPRX
- Stock Information
- Founded
- MLTX 2021
- CPRX 2002
- Country
- MLTX Switzerland
- CPRX United States
- Employees
- MLTX N/A
- CPRX N/A
- Industry
- MLTX Biotechnology: Pharmaceutical Preparations
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- MLTX Health Care
- CPRX Health Care
- Exchange
- MLTX Nasdaq
- CPRX Nasdaq
- Market Cap
- MLTX 2.3B
- CPRX 2.9B
- IPO Year
- MLTX N/A
- CPRX 2006
- Fundamental
- Price
- MLTX $39.74
- CPRX $22.76
- Analyst Decision
- MLTX Strong Buy
- CPRX Strong Buy
- Analyst Count
- MLTX 8
- CPRX 7
- Target Price
- MLTX $80.50
- CPRX $32.29
- AVG Volume (30 Days)
- MLTX 425.4K
- CPRX 1.0M
- Earning Date
- MLTX 05-20-2025
- CPRX 05-07-2025
- Dividend Yield
- MLTX N/A
- CPRX N/A
- EPS Growth
- MLTX N/A
- CPRX 178.13
- EPS
- MLTX N/A
- CPRX 1.57
- Revenue
- MLTX N/A
- CPRX $534,645,999.00
- Revenue This Year
- MLTX $103.42
- CPRX $15.59
- Revenue Next Year
- MLTX N/A
- CPRX $8.90
- P/E Ratio
- MLTX N/A
- CPRX $14.51
- Revenue Growth
- MLTX N/A
- CPRX 29.97
- 52 Week Low
- MLTX $31.42
- CPRX $14.47
- 52 Week High
- MLTX $58.26
- CPRX $26.16
- Technical
- Relative Strength Index (RSI)
- MLTX 51.51
- CPRX 46.01
- Support Level
- MLTX $39.86
- CPRX $22.94
- Resistance Level
- MLTX $42.90
- CPRX $25.01
- Average True Range (ATR)
- MLTX 2.15
- CPRX 0.83
- MACD
- MLTX 0.03
- CPRX -0.05
- Stochastic Oscillator
- MLTX 48.60
- CPRX 46.56
About MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).